UBS’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$672K Sell
5,100
-1,000
-16% -$132K ﹤0.01% 3994
2014
Q2
$763K Buy
6,100
+3,400
+126% +$439K ﹤0.01% 3814
2014
Q1
$433K Buy
2,700
+100
+4% +$16.5K ﹤0.01% 4388
2013
Q4
$350K Buy
2,600
+100
+4% +$12.8K ﹤0.01% 4690
2013
Q3
$271K Sell
2,500
-8,600
-77% -$930K ﹤0.01% 4825
2013
Q2
$940K Buy
+11,100
New +$993K ﹤0.01% 3413

Other funds holding ATHN

UBS's ATHN Position: Q3 2014 in Review

UBS reduced its Athenahealth, Inc. (ATHN) stake by 95% in Q3 2014, selling an estimated $2.63M and leaving 1,044 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #5600.

UBS first reported a position in ATHN in Q2 2013 and has held it in 4 quarters since. The position peaked at $2.63M in Q2 2014. 212 funds tracked by Wall St. Rank hold ATHN as of Q3 2014.

  • UBS held 1,044 shares of Athenahealth, Inc. worth $137K as of Q3 2014.
  • UBS sold 19,942 Athenahealth, Inc. shares in Q3 2014, an estimated $2.63M.
  • Athenahealth, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5600 holding.
  • UBS first reported a position in Athenahealth, Inc. in Q2 2013 and has held it in 4 quarters since.
  • UBS's Athenahealth, Inc. position peaked at $2.63M in Q2 2014.
  • 212 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.